BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6763999)

  • 1. Presence of immunoreactive luteinizing hormone-releasing factor in hydatidiform mole as compared with normal human trophoblastic tissue.
    Osathanondh R; Elkind-Hirsch KE
    Placenta Suppl; 1981; 3():257-61. PubMed ID: 6763999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study of the properties of human chorionic gonadotropin (hCG) from total hydatidiform mole with low hCG immunoactivity].
    Imamichi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1205-14. PubMed ID: 4040949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear DNA content of trophoblastic tumors.
    Sugimori H; Kashimura Y; Kashimura M; Taki I
    Acta Cytol; 1978; 22(6):542-5. PubMed ID: 216204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of the production of chorionic gonadotropin by the cells of trophoblastic tumors (immunohistochemical research)].
    Pozharisskiĭ KM; Zueva EE; Nikitin AIu
    Vopr Onkol; 1988; 34(8):945-51. PubMed ID: 2844022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI; Kacinski BM; Stanley ER
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytological distribution of chorionic gonadotropin subunit and placental lactogen messenger RNA in neoplasms derived from human placenta.
    Hoshina M; Hussa R; Pattillo R; Boime I
    J Cell Biol; 1983 Oct; 97(4):1200-6. PubMed ID: 6619191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of human chorionic gonadotropin/human luteinizing hormone receptors in human gestational trophoblastic neoplasms.
    Lei ZM; Rao CV; Ackerman DM; Day TG
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1236-41. PubMed ID: 1592864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative study of nuclear DNA of trophoblastic cells analysis of nuclear DNA distribution and clinical outcome of hydatidiform mole.
    Kashimura Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):699-705. PubMed ID: 6864028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibin: a new circulating marker of hydatidiform mole?
    Yohkaichiya T; Fukaya T; Hoshiai H; Yajima A; de Kretser DM
    BMJ; 1989 Jun; 298(6689):1684-6. PubMed ID: 2503176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotropic activity of acidic isoelectric variants of human chorionic gonadotropin from trophoblastic tumors.
    Mann K; Schneider N; Hoermann R
    Endocrinology; 1986 Apr; 118(4):1558-66. PubMed ID: 3004921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical demonstration of luteinizing hormone-releasing factor-like material in human syncytiotrophoblast and trophoblastic tumours.
    Seppälä M; Wahlström T; Lehtovirta P; Lee JN; Leppälouto J
    Clin Endocrinol (Oxf); 1980 May; 12(5):441-51. PubMed ID: 6253107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha subunit in gestational trophoblastic disease.
    Kohorn EI; Caldwell BV; Cortes JM
    Placenta Suppl; 1981; 3():231-40. PubMed ID: 6306644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of incompletely sialylated human chorionic gonadotropin by peanut agglutinin in choriocarcinoma.
    Nishimura R; Mizuochi T; Utsunomiya T; Ide K; Kobata A; Mochizuki M
    Jpn J Exp Med; 1985 Apr; 55(2):75-8. PubMed ID: 4046212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An immunohistochemical study in conjunction with the enzyme labelled antibody method to discern the relevancy between the localization of hCG, hPL and the functions of the normal and malignant trophoblast (author's transl)].
    Tanaka A
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 May; 34(5):579-88. PubMed ID: 6282995
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolation and physicochemical properties of human chorionic gonadotropin of hydatidiform mole.
    Imamura S
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1631-6. PubMed ID: 7240828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.